+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Namzaric"

Memantine HCl Global Market Report 2025 - Product Thumbnail Image

Memantine HCl Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Namzaric is a combination drug used to treat Alzheimer's Disease. It is a combination of memantine hydrochloride and donepezil hydrochloride, two drugs that are commonly used to treat Alzheimer's Disease. Namzaric is designed to provide a more effective treatment for Alzheimer's Disease than either drug alone. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe Alzheimer's Disease in adults. Namzaric is a relatively new drug in the Alzheimer's Disease market, but it has quickly become a popular treatment option. It is designed to provide a more effective treatment than either drug alone, and it is generally well-tolerated by patients. The Namzaric market is highly competitive, with several major pharmaceutical companies competing for market share. Companies in the market include Allergan, Actavis, Mylan, and Teva Pharmaceuticals. Show Less Read more